Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study
暂无分享,去创建一个
F. Ingegnoli | N. Del Papa | R. De Angelis | V. Riccieri | S. Papa | E. Cipolletta | A. Spinella | D. Giuggioli | M. de Pinto | G. Armentaro | G. Pellegrino | Anna Maria Risa
[1] L. Magnani,et al. Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology , 2021, The Journal of Rheumatology.
[2] K. Zakrzewska,et al. Insights into the knowledge of complex diseases: Environmental infectious/toxic agents as potential etiopathogenetic factors of systemic sclerosis. , 2021, Journal of autoimmunity.
[3] C. Bruni,et al. The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients , 2021, Pharmaceuticals.
[4] P. Sarafidis,et al. Nailfold Capillaroscopy in Systemic Sclerosis Patients with and without Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis , 2021, Journal of clinical medicine.
[5] M. Vonk,et al. Change of the microvascularization in systemic sclerosis, a matter of air. , 2021, Best practice & research. Clinical rheumatology.
[6] F. Cacciapaglia,et al. Pulmonary arterial hypertension: guidelines and unmet clinical needs. , 2021, Reumatismo.
[7] G. Giannakoulas,et al. Peripheral microangiopathy in precapillary pulmonary hypertension: a nailfold video capillaroscopy prospective study , 2020, Respiratory Research.
[8] G. Kitas,et al. Nailfold videocapillaroscopy: a novel possible surrogate marker for the evaluation of peripheral microangiopathy in pulmonary arterial hypertension , 2020, Scandinavian journal of rheumatology.
[9] R. Caporali,et al. High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis , 2020, Arthritis Research & Therapy.
[10] A. Iagnocco,et al. Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. , 2020, Autoimmunity reviews.
[11] M. Cutolo,et al. Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. , 2019, Rheumatology.
[12] M. Humbert,et al. Screening for pulmonary arterial hypertension in systemic sclerosis , 2019, European Respiratory Review.
[13] Y. Liu,et al. Diagnostic value of nailfold videocapillaroscopy in systemic sclerosis secondary pulmonary arterial hypertension: a meta‐analysis , 2018, Internal medicine journal.
[14] M. Biase,et al. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension. , 2017, Microvascular research.
[15] C. Denton,et al. SYSTEMIC SCLEROSIS , 2008 .
[16] M. Boubaya,et al. Mapping and predicting mortality from systemic sclerosis , 2017, Annals of the rheumatic diseases.
[17] M. Cutolo,et al. Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis. , 2017, Seminars in arthritis and rheumatism.
[18] J. Varga,et al. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities , 2017 .
[19] Simon Gibbs,et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.
[20] F. Iannone,et al. Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases , 2015, Internal and Emergency Medicine.
[21] Oliver Distler,et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.
[22] M. Mayes,et al. An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .
[23] P. Boracchi,et al. Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database. , 2013, Microvascular research.
[24] C. Vizza,et al. Systemic sclerosis patients with and without pulmonary arterial hypertension: a nailfold capillaroscopy study. , 2013, Rheumatology.
[25] L. Frumkin. The Pharmacological Treatment of Pulmonary Arterial Hypertension , 2012, Pharmacological Reviews.
[26] W. Grassi,et al. Interreader Reliability in Assessment of Nailfold Capillary Abnormalities by Beginners: Pilot Study of an Intensive Videocapillaroscopy Training Program , 2012, The Journal of Rheumatology.
[27] Y. Allanore,et al. Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. , 2012, Rheumatology.
[28] M. Cutolo,et al. Timing of transition between capillaroscopic patterns in systemic sclerosis. , 2012, Arthritis and rheumatism.
[29] M. Humbert,et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. , 2011, Arthritis and rheumatism.
[30] J. Stamm,et al. Overview of current therapeutic approaches for pulmonary hypertension , 2011, Pulmonary circulation.
[31] E. Hachulla,et al. Diagnosis and Classification of Systemic Sclerosis , 2011, Clinical reviews in allergy & immunology.
[32] A. Silman,et al. Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .
[33] E. Feierl,et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database , 2010, Annals of the rheumatic diseases.
[34] A. Firth,et al. Idiopathic pulmonary arterial hypertension , 2010, Disease Models & Mechanisms.
[35] D. Playford,et al. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis , 2009, Internal medicine journal.
[36] P. Postmus,et al. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis , 2008, Annals of the rheumatic diseases.
[37] F. Schmidt. Meta-Analysis , 2008 .
[38] T. Medsger,et al. Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.
[39] M. Cutolo,et al. New Kids on the Block in SSc-PAH: May We Futurely Nail It Additionally Down to Capillaroscopy? A Systematic Literature Review. , 2019, The Journal of rheumatology.
[40] A. Herrick,et al. Digital ulcers in systemic sclerosis , 2017, Rheumatology.
[41] Teresa Foo,et al. : SYSTEMATIC LITERATURE REVIEW , 2004 .